Table 2.
Vector Type | Package Limitation | Superiority | Deficiency | References |
---|---|---|---|---|
AAV | 4.5 kb | low immunogenicity, serotype-related targeting, stable transgene expression | low packaging capacity | [32] |
LV | 8 kb | large packaging capacity, low cell cycle tendency | long lasting expression of Cas9 | [33] |
AV | >8 kb | large packaging capacity, no-integration to host genome | high immunogenicity | [17] |